137 related articles for article (PubMed ID: 4992254)
1. Venous responses to prostaglandin F2 alpha.
Mark AL; Schmid PG; Eckstein JW; Wendling MG
Am J Physiol; 1971 Jan; 220(1):222-6. PubMed ID: 4992254
[No Abstract] [Full Text] [Related]
2. Effects of prostaglandin B2 on vascular tone and reactivity.
Greenberg S; Diecke FP; Kadowitz PJ; Long JP
Life Sci; 1975 Feb; 16(3):363-74. PubMed ID: 1128154
[No Abstract] [Full Text] [Related]
3. Effects of monoamines on the capacity of isolated veins.
Clement D; Vanhoutte P
Arch Int Pharmacodyn Ther; 1967 Mar; 166(1):181-3. PubMed ID: 6034317
[No Abstract] [Full Text] [Related]
4. Responses of saphenous and mesenteric veins to administration of dopamine.
Mark AL; Iizuka T; Wendling MG; Eckstein JW
J Clin Invest; 1970 Feb; 49(2):259-66. PubMed ID: 4391558
[TBL] [Abstract][Full Text] [Related]
5. Effect of prostaglandin F2 alpha (PGF2 alpha) on arterial and venous contractility and 45Ca uptake.
Greenberg S; Kadowitz PJ; Diecke FP; Long JP
Arch Int Pharmacodyn Ther; 1973 Oct; 205(2):381-98. PubMed ID: 4766553
[No Abstract] [Full Text] [Related]
6. Potentiation of adrenergic venomotor responses in dogs by cardiac glycosides.
Brender D; Vanhoutte PM; Shepherd JT
Circ Res; 1969 Nov; 25(5):597-606. PubMed ID: 5351327
[No Abstract] [Full Text] [Related]
7. Effects of sympathetic and central nervous system alterations on the blood pressure responses to phentolamine.
Hilliard CC; Bagwell EE; Daniell HB
J Pharmacol Exp Ther; 1972 Mar; 180(3):743-7. PubMed ID: 4401160
[No Abstract] [Full Text] [Related]
8. Effect of cooling on beta-receptor mechanisms in isolated saphenous veins of the dog.
Vanhoutte PM; Shepherd JT
Arch Int Pharmacodyn Ther; 1970 May; 185(1):208. PubMed ID: 4394263
[No Abstract] [Full Text] [Related]
9. Mechanism of the vasoconstrictor action of prostaglandin B.
Greenberg S; Wilson WR; Howard L
J Pharmacol Exp Ther; 1974 Jul; 190(1):59-69. PubMed ID: 4211165
[No Abstract] [Full Text] [Related]
10. Influence of prostaglandins on adrenergic transmission to vascular smooth muscle.
Kadowitz PJ; Sweet CS; Brody MJ
Circ Res; 1972 Sep; 31(9):Suppl 2:36-50. PubMed ID: 4403486
[No Abstract] [Full Text] [Related]
11. Influence of inhibitors of prostaglandin synthesis on venoconstrictor responses to bradykinin.
Goldberg MR; Chapnick BM; Joiner PD; Hyman AL; Kadowitz PJ
J Pharmacol Exp Ther; 1976 Aug; 198(2):357-65. PubMed ID: 948031
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of venoconstrictor responses by prostaglandin E1.
Hedwall PR; Abdel-Sayed WA; Schmid PG; Abboud FM
Proc Soc Exp Biol Med; 1970 Dec; 135(3):757-9. PubMed ID: 4321033
[No Abstract] [Full Text] [Related]
13. Role of acetylcholine in the renal vasoconstrictor response to sympathetic nerve stimulation in the dog.
McGiff JC; Burns RB; Blumenthal MR
Circ Res; 1967 Jun; 20(6):616-29. PubMed ID: 6057695
[No Abstract] [Full Text] [Related]
14. Proceedings: Further studies on the mode of action of ergotamine on canine vein strips.
Müller-Schweinitzer E
Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R68. PubMed ID: 4276620
[No Abstract] [Full Text] [Related]
15. Modification of the cardiovascular response to isoproterenol by pilocarpine.
Daniell HB; Bagwell EE
Arch Int Pharmacodyn Ther; 1969 Sep; 181(1):141-52. PubMed ID: 5350777
[No Abstract] [Full Text] [Related]
16. Studies on the peripheral mode of action of dihydroergotamine in human and canine veins.
Müller-Schweinitzer E
Eur J Pharmacol; 1974 Jul; 27(2):231-7. PubMed ID: 4854492
[No Abstract] [Full Text] [Related]
17. Influence of sympathetic stimulation and vasoactive substances on the canine pulmonary veins.
Kadowitz PJ; Joiner PD; Hyman AL
J Clin Invest; 1975 Aug; 56(2):354-65. PubMed ID: 1150876
[TBL] [Abstract][Full Text] [Related]
18. Prolonged effects of reserpine administration on adrenoceptor activity in dogs.
Cavero I; Jandhyala BS; Buckley JP
J Pharm Pharmacol; 1971 Dec; 23(12):988-9. PubMed ID: 4402037
[No Abstract] [Full Text] [Related]
19. Interaction between alpha adrenergic and serotonergic activation of canine saphenous veins.
Curro FA; Greenberg S; Verbeuren TJ; Vanhoutte PM
J Pharmacol Exp Ther; 1978 Dec; 207(3):936-49. PubMed ID: 215746
[TBL] [Abstract][Full Text] [Related]
20. Enhanced prostaglandin synthesis contributes to the venoconstrictor activity of ergotamine.
Müller-Schweinitzer E; Brundell J
Blood Vessels; 1975; 12(4):193-205. PubMed ID: 1174710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
